Large-scale testing (Phase 3)Ended earlyNCT04689594
What this trial is testing
Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group
Who this might be right for
Superficial Esophageal Cancer
CellSeed Inc. 1